{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:51:05Z","timestamp":1789761065563,"version":"4.0.1"},"reference-count":36,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T00:00:00Z","timestamp":1657065600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Dyslipidemia is a well-recognized risk factor for diabetic kidney disease (DKD) in patients with type 2 diabetes (T2D). Growing evidences have shown that compared with the traditional lipid parameters, some lipid ratios may provide additional information of lipid metabolism. Thus, the present study aimed to investigate which lipid index was most related to DKD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>This study was a cross-sectional study that enrolled patients with T2D from January 2021 to October 2021. Each participant was screened for DKD, and the diagnostic criterion for DKD is estimated glomerular filtration rate (eGFR) &amp;lt; 60 ml\/min\/1.73 m<jats:sup>2<\/jats:sup> or urinary albumin-to-creatinine ratio (UACR) \u2265 30 mg\/g for 3 months. Fasting blood was collected to determine lipid profiles by an automatic biochemical analyzer, and lipid ratios were calculated based on corresponding lipid parameters. Spearman\u2019s correlation analyses were conducted to assess the correlations between lipid indices and kidney injury indices, and binary logistic regression analyses were conducted to explore the relationship between lipid indices and the risk of DKD.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 936 patients with T2D were enrolled in the study, 144 (15.38%) of whom had DKD. The LDL-C\/Apo B ratios were positively correlated with eGFR (<jats:italic>r =<\/jats:italic> 0.146, <jats:italic>p &amp;lt;<\/jats:italic> 0.05) and inversely correlated to cystatin C and UACR (<jats:italic>r =<\/jats:italic> -0.237 and -0.120, both <jats:italic>p &amp;lt;<\/jats:italic> 0.001). Multiple logistic regression demonstrated that even after adjusting for other clinical covariates, the LDL-C\/Apo B ratios were negatively related to DKD, and the odds ratio (95% confidence interval) was 0.481 (0.275\u20130.843). Furthermore, subgroup analyses revealed that compared with patients with normal lipid profiles and a high LDL-C\/Apo B ratio, the odds ratio of DKD in patients with normal lipid metabolism and a low LDL-C\/Apo B ratio was 2.205 (1.136-4.280) after adjusting for other clinical covariates.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>In patients with T2D, the LDL-c\/Apo B ratio was most closely associated with DKD among various lipid indices, and a lower LDL-C\/Apo B ratio was associated with increased risks of DKD among patients with T2D.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.888599","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T09:56:03Z","timestamp":1657187763000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":14,"title":["Comparisons of the Relationships Between Multiple Lipid Indices and Diabetic Kidney Disease in Patients With Type 2 Diabetes: A Cross-Sectional Study"],"prefix":"10.3389","volume":"13","author":[{"given":"Chun-feng","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wang-shu","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen-hua","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling-yan","family":"Hua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-qin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-yan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,7,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2015.12.018","article-title":"Diabetes Mellitus: The Linkage Between Oxidative Stress, Inflammation, Hypercoagulability and Vascular Complications","volume":"30","author":"Domingueti","year":"2016","journal-title":"J Diabetes Complications"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.06.017","article-title":"Urinary Neutrophil Gelatinase-Associated Lipocalin in Type 2 Diabetes: Relation to Nephropathy and Retinopathy","volume":"12","author":"Hosny","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755","article-title":"Development and Progression of Nephropathy in Type 2 Diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64)","volume":"63","author":"Adler","year":"2003","journal-title":"Kidney Int"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-003-1111-y","article-title":"Diabetic Dyslipidaemia: From Basic Research to Clinical Practice","volume":"46","author":"Taskinen","year":"2003","journal-title":"Diabetologia"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1681\/ASN.2004080629","article-title":"Statins Prevent Oxidized LDL-Induced Injury of Glomerular Podocytes by Activating the Phosphatidylinositol 3-Kinase\/AKT-Signaling Pathway","volume":"16","author":"Bussolati","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"B6","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.phrs.2016.01.005","article-title":"The Effect of Statins on Microalbuminuria, Proteinuria, Progression of Kidney Function, and All-Cause Mortality in Patients With non-End Stage Chronic Kidney Disease: A Meta-Analysis","volume":"105","author":"Zhang","year":"2016","journal-title":"Pharmacol Res"},{"key":"B7","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s12902-021-00726-5","article-title":"Association of Apolipoproteins A1 and B With Type 2 Diabetes and Fasting Blood Glucose: A Cross-Sectional Study","volume":"21","author":"Gao","year":"2021","journal-title":"BMC Endocr Disord"},{"key":"B8","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1186\/s12933-021-01381-9","article-title":"Association Between Apolipoprotein B\/A1 Ratio and Coronary Plaque Vulnerability in Patients With Atherosclerotic Cardiovascular Disease: An Intravascular Optical Coherence Tomography Study","volume":"20","author":"Deng","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.5551\/jat.60954","article-title":"Clinical Importance of the LDL-C\/apolipoprotein B Ratio for Neointimal Formation After Everolimus-Eluting Stent Implantations","volume":"29","author":"Akutsu","year":"2022","journal-title":"J Atheroscler Thromb"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1007\/s11255-020-02550-7","article-title":"Serum Apolipoprotein B\/apolipoprotein A1 Ratio is Associated With the Progression of Diabetic Kidney Disease to Renal Replacement Therapy","volume":"52","author":"Zhao","year":"2020","journal-title":"Int Urol Nephrol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2011.05.004","article-title":"Triglyceride-High-Density Lipoprotein Cholesterol is Associated With Microvascular Complications in Type 2 Diabetes Mellitus","volume":"61","author":"Zoppini","year":"2012","journal-title":"Metabolism"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.atherosclerosis.2015.03.034","article-title":"Associations of Multiple Lipoprotein and Apolipoprotein Measures With Worsening of Glycemia and Incident Type 2 Diabetes in 6607 non-Diabetic Finnish Men","volume":"240","author":"Fizelova","year":"2015","journal-title":"Atherosclerosis"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.2337\/dc13-S067","article-title":"American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus","year":"2013","journal-title":"Diabetes Care"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1114248","article-title":"Estimating Glomerular Filtration Rate From Serum Creatinine and Cystatin C","volume":"367","author":"Inker","year":"2012","journal-title":"N Engl J Med"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.2337\/dc14-1296","article-title":"Diabetic Kidney Disease: A Report From an ADA Consensus Conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s40620-020-00739-8","article-title":"Atherogenic Dyslipidemia and Diabetic Nephropathy","volume":"33","author":"Russo","year":"2020","journal-title":"J Nephrol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.2174\/0929867328666210419132807","article-title":"The Role of Cholesterol Homeostasis in Diabetic Kidney Disease","volume":"28","author":"Chen","year":"2021","journal-title":"Curr Med Chem"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.dsx.2018.04.017","article-title":"Utility of Urinary Biomarkers as a Diagnostic Tool for Early Diabetic Nephropathy in Patients With Type 2 Diabetes Mellitus","volume":"12","author":"Vijay","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ki.5001834","article-title":"Lipotoxicity","volume":"70","author":"Weinberg","year":"2006","journal-title":"Kidney Int"},{"key":"B20","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1016\/j.amjms.2019.11.004","article-title":"Renal Lipid Metabolism and Lipotoxicity in Diabetes","volume":"359","author":"Thongnak","year":"2020","journal-title":"Am J Med Sci"},{"key":"B21","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1046\/j.1523-1755.2000.00165.x","article-title":"Plasma Lipids and Risk of Developing Renal Dysfunction: The Atherosclerosis Risk in Communities Study","volume":"58","author":"Muntner","year":"2000","journal-title":"Kidney Int"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.2337\/db05-1620","article-title":"Risk Factors for Renal Dysfunction in Type 2 Diabetes: U.K. Prospective Diabetes Study 74","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1053\/j.ajkd.2015.05.011","article-title":"Impact of the Triglycerides to High-Density Lipoprotein Cholesterol Ratio on the Incidence and Progression of CKD: A Longitudinal Study in a Large Japanese Population","volume":"66","author":"Tsuruya","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.2337\/dc16-1246","article-title":"Plasma Triglycerides and HDL-C Levels Predict the Development of Diabetic Kidney Disease in Subjects With Type 2 Diabetes: The AMD Annals Initiative","volume":"39","author":"Russo","year":"2016","journal-title":"Diabetes Care"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.471","article-title":"Prevention of Diabetic Nephropathy by Tight Target Control in an Asian Population With Type 2 Diabetes Mellitus: A 4-Year Prospective Analysis","volume":"170","author":"Tu","year":"2010","journal-title":"Arch Intern Med"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-009-1597-z","article-title":"Lipid and Inflammatory Biomarkers and Kidney Function Decline in Type 2 Diabetes","volume":"53","author":"Lin","year":"2010","journal-title":"Diabetologia"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14939","article-title":"Potential Relationship Between Egfrcystatin C\/eGFRcreatinine -Ratio and Glomerular Basement Membrane Thickness in Diabetic Kidney Disease","volume":"9","author":"\u00d6berg","year":"2021","journal-title":"Physiol Rep"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2019.11.044","article-title":"Cardiometabolic-Based Chronic Disease, Adiposity and Dysglycemia Drivers: JACC State-Of-the-Art Review","volume":"75","author":"Mechanick","year":"2020","journal-title":"Am Coll Cardiol"},{"key":"B29","first-page":"199","article-title":"The Small, Dense LDL Phenotype and the Risk of Coronary Heart Disease: Epidemiology, Patho-Physiology and Therapeutic Aspects","volume":"25","author":"Koba","year":"1999","journal-title":"Diabetes Metab"},{"key":"B30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1080\/13813455.2016.1195411","article-title":"Usefulness of the LDL-C\/apo B Ratio in the Overall Evaluation of Atherogenicity of Lipid Profile","volume":"123","author":"Kaneva","year":"2017","journal-title":"Arch Physiol Biochem"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.52.343","article-title":"Low-Density Lipoprotein Cholesterol\/Apolipoprotein B Ratio may be a Useful Index That Differs in Statin-Treated Patients With and Without Coronary Artery Disease: A Case Control Study","volume":"52","author":"Tani","year":"2011","journal-title":"Int Heart J"},{"key":"B32","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s12944-018-0671-2","article-title":"Small Dense Low Density Lipoprotein-Cholesterol and Cholesterol Ratios to Predict Arterial Stiffness Progression in Normotensive Subjects Over a 5-Year Period","volume":"17","author":"Li","year":"2018","journal-title":"Lipids Health Dis"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1016\/j.cca.2012.09.010","article-title":"Small Dense LDL: An Emerging Risk Factor for Cardiovascular Disease","volume":"414","author":"Hirayama","year":"2012","journal-title":"Clin Chim Acta"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/life11060504","article-title":"Oxidized LDL Modifies the Association Between Proteinuria and Deterioration of Kidney Function in Proteinuric Diabetic Kidney Disease","volume":"11","author":"Roumeliotis","year":"2021","journal-title":"Life (Basel)"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1479164121992524","DOI":"10.1177\/1479164121992524","article-title":"Vascular Inflammation, Atherosclerosis, and Lipid Metabolism and the Occurrence of non-High Albuminuria Diabetic Kidney Disease: A Cross-Sectional Study","volume":"18","author":"Yang","year":"2021","journal-title":"Diabetes Vasc Dis Res"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-016-0491-5","article-title":"Dapagliflozin Decreases Small Dense Low-Density Lipoprotein-Cholesterol and Increases High-Density Lipoprotein 2-Cholesterol in Patients With Type 2 Diabetes: Comparison With Sitagliptin","volume":"16","author":"Hayashi","year":"2017","journal-title":"Cardiovasc Diabetol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.888599\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T09:56:09Z","timestamp":1657187769000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.888599\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,6]]},"references-count":36,"alternative-id":["10.3389\/fendo.2022.888599"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.888599","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,7,6]]},"article-number":"888599"}}